Clinical and paraclinical characteristics and treatment outcomes of endoscopic retrograde cholangiopancreatography (ercp)-guided biliary stent placement in patients with malignant biliary obstruction

Tran Van Thao; Tran Tu Oanh

doi:10.63583/1773hd42

Các tác giả

Tran Van Thao Thanh Thuy District Medical Center, Phu Tho Province
Tran Tu Oanh Medical and Pharmaceutical University Hospital, VNUH

DOI:

https://doi.org/10.63583/1773hd42

Từ khóa:

Malignant biliary obstruction, endoscopic retrograde cholangiopancreatography, biliary stent

Tóm tắt

Objective: To describe the clinical and paraclinical characteristics and evaluate the treatment outcomes of ERCP-guided biliary stenting in patients with malignant biliary obstruction due to cancer. Subject and method: A prospective, non-randomized, longitudinal, convenience-sample interventional study was conducted on 97 patients with malignant biliary obstruction due to cancer who underwent ERCP-guided biliary stenting from December 2019 to January 2024. Result: The study included 97 patients with malignant biliary obstruction due to cancer, with a mean age of 63.1 ± 11.8 years, and 68.0% were male. All patients presented with jaundice, accompanied by anorexia (94.8%), weight loss (88.7%), and abdominal pain (83.5%). Pre-procedure, 100% had elevated total bilirubin, with 58.8% >256.5μmol/L; elevated liver enzymes (AST, ALT, GGT); and hypoalbuminemia in 59.8%. The technical success rate of the initial stent placement was 95.9%, with a higher usage of metal stents (56.7%). After one month, significant improvements were observed in bilirubin, liver enzymes, and creatinine levels (p<0.001); albumin and prothrombin time also increased significantly. Conclusion: ERCP-guided biliary stenting is an effective and safe method for palliating malignant biliary obstruction due to cancer, leading to improved clinical symptoms and liver function, with a high technical success rate and minimal severe complications.

Tài liệu tham khảo

1. Premkumar K., Selvi C. (2021). Endoscopic Stenting of Malignant Biliary Obstruction and Its Impact on Quality of Life. .

2. Wang W., Zhang C., Li B. et al (2025). Clinical evaluation of endoscopic biliary stenting in treatment of malignant obstructive jaundice. World J Gastrointest Surg, 17(1).

3. Cheung K.-L. (1995). Endoscopic Stenting for Malignant Biliary Obstruction. Arch Surg, 130(2), 204.

4. Bagul A., Pollard C., Dennison A.R. (2010). A review of problems following insertion of biliary stents illustrated by an unusual complication. Ann R Coll Surg Engl, 92(4), e27-31.

5. Luman W., Cull A., và Palmer K.R. (1997). Quality of life in patients stented for malignant biliary obstructions. Eur J Gastroenterol Hepatol, 9(5), 481-484.

6. Sohn S.H., Park J.H., Kim K.H. et al. (2017). Complications and management of forgotten long-term biliary stents. World J Gastroenterol, 23(4), 622-628.

7. Jinkins L.J., Parmar A.D., Han Y. et al. (2013). Current Trends in Preoperative Biliary Stenting in Pancreatic Cancer Patients. Surgery, 154(2), 179-189.

8. Lee T.H. (2013). Technical Tips and Issues of Biliary Stenting, Focusing on Malignant Hilar Obstruction. Clin Endosc, 46(3), 260-266.